TC BioPharm Revenue and Competitors

Location

#4866

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • TC BioPharm's estimated annual revenue is currently $12.7M per year.(i)
  • TC BioPharm's estimated revenue per employee is $189,701

Employee Data

  • TC BioPharm has 67 Employees.(i)
  • TC BioPharm grew their employee count by 2% last year.

TC BioPharm's People

NameTitleEmail/Phone
1
EVP Clinical OperationsReveal Email/Phone
2
Head Human Biology Lab OperationsReveal Email/Phone
3
SVP OperationsReveal Email/Phone
4
Head ProductionReveal Email/Phone
5
Senior Director FinanceReveal Email/Phone
6
Chief Operating Officer and FounderReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Director Product DevelopmentReveal Email/Phone
9
Production ManagerReveal Email/Phone
10
Process Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$1.2M27112%$440MN/A
#7
$54.6M2820%$132.9MN/A
#8
$9.3M60-37%N/AN/A
#9
$21.2M13712%N/AN/A
#10
$408.2M164611%£994.6MN/A
Add Company

What Is TC BioPharm?

TC BioPharm’s mission is to develop and commercialise innovative cell-based products to treat disease, improving patient health and Quality of Life.\n\nTC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell®, in renal cell cancinoma, non-small cell lung cancer and melanoma patients. \n\nWe have a growing team based in our Glasgow and Edinburgh offices, alongside a wide range of scientific advisors, and partner organisations.

keywords:N/A

N/A

Total Funding

67

Number of Employees

$12.7M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TC BioPharm News

2022-04-17 - TC BioPharm Donates to Leukemia and Lymphoma Society in ...

TC BioPharm is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell...

2022-04-06 - TC BioPharm Receives CryoTC® Trademark for Proprietary ...

TC BioPharm is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell...

2022-03-22 - TC BioPharm to initiate Phase IIb/III trial of AML allogeneic cell ...

To detect, act on and destroy liquid and solid tumours, TC BioPharm leverages an allogeneic approach in unmodified and CAR-modified gamma-delta...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M67-8%N/A
#2
$8.7M67-20%N/A
#3
$8.6M68-11%N/A
#4
$13M69-3%N/A
#5
$14.1M69-14%N/A